These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21942823)

  • 1. Revisiting peptide amphiphilicity for membrane pore formation.
    Lorin A; Noël M; Provencher MÈ; Turcotte V; Masson C; Cardinal S; Lagüe P; Voyer N; Auger M
    Biochemistry; 2011 Nov; 50(43):9409-20. PubMed ID: 21942823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary structure in de novo designed peptides induced by electrostatic interaction with a lipid bilayer membrane.
    Nygren P; Lundqvist M; Liedberg B; Jonsson BH; Ederth T
    Langmuir; 2010 May; 26(9):6437-48. PubMed ID: 20349970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the angle subtended by the positively charged helix face on the membrane activity of amphipathic, antibacterial peptides.
    Wieprecht T; Dathe M; Epand RM; Beyermann M; Krause E; Maloy WL; MacDonald DL; Bienert M
    Biochemistry; 1997 Oct; 36(42):12869-80. PubMed ID: 9335545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determining the mode of action involved in the antimicrobial activity of synthetic peptides: a solid-state NMR and FTIR study.
    Lorin A; Noël M; Provencher MÈ; Turcotte V; Cardinal S; Lagüe P; Voyer N; Auger M
    Biophys J; 2012 Oct; 103(7):1470-9. PubMed ID: 23062339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide hydrophobicity controls the activity and selectivity of magainin 2 amide in interaction with membranes.
    Wieprecht T; Dathe M; Beyermann M; Krause E; Maloy WL; MacDonald DL; Bienert M
    Biochemistry; 1997 May; 36(20):6124-32. PubMed ID: 9166783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of membrane-inserting peptides: spectroscopic characterization with and without lipid bilayers.
    Chung LA; Thompson TE
    Biochemistry; 1996 Sep; 35(35):11343-54. PubMed ID: 8784189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GALA: a designed synthetic pH-responsive amphipathic peptide with applications in drug and gene delivery.
    Li W; Nicol F; Szoka FC
    Adv Drug Deliv Rev; 2004 Apr; 56(7):967-85. PubMed ID: 15066755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of variations in the structure of a polyleucine-based alpha-helical transmembrane peptide on its interaction with phosphatidylglycerol bilayers.
    Liu F; Lewis RN; Hodges RS; McElhaney RN
    Biochemistry; 2004 Mar; 43(12):3679-87. PubMed ID: 15035638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of amphiphilic alpha-helical model peptides with systematically varied hydrophobic-hydrophilic balance and their interaction with lipid- and bio-membranes.
    Kiyota T; Lee S; Sugihara G
    Biochemistry; 1996 Oct; 35(40):13196-204. PubMed ID: 8855958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and characterization of anchoring amphiphilic peptides and their interactions with lipid vesicles.
    Percot A; Zhu XX; Lafleur M
    Biopolymers; 1999 Nov; 50(6):647-55. PubMed ID: 10508967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane topology of a 14-mer model amphipathic peptide: a solid-state NMR spectroscopy study.
    Ouellet M; Doucet JD; Voyer N; Auger M
    Biochemistry; 2007 Jun; 46(22):6597-606. PubMed ID: 17487978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anionic phospholipids modulate peptide insertion into membranes.
    Liu LP; Deber CM
    Biochemistry; 1997 May; 36(18):5476-82. PubMed ID: 9154930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide helicity and membrane surface charge modulate the balance of electrostatic and hydrophobic interactions with lipid bilayers and biological membranes.
    Dathe M; Schümann M; Wieprecht T; Winkler A; Beyermann M; Krause E; Matsuzaki K; Murase O; Bienert M
    Biochemistry; 1996 Sep; 35(38):12612-22. PubMed ID: 8823199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane binding and structure of de novo designed alpha-helical cationic coiled-coil-forming peptides.
    Vagt T; Zschörnig O; Huster D; Koksch B
    Chemphyschem; 2006 Jun; 7(6):1361-71. PubMed ID: 16680794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggregation and porin-like channel activity of a beta sheet peptide.
    Thundimadathil J; Roeske RW; Jiang HY; Guo L
    Biochemistry; 2005 Aug; 44(30):10259-70. PubMed ID: 16042403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solution structure and membrane interactions of the antimicrobial peptide fallaxidin 4.1a: an NMR and QCM study.
    Sherman PJ; Jackway RJ; Gehman JD; Praporski S; McCubbin GA; Mechler A; Martin LL; Separovic F; Bowie JH
    Biochemistry; 2009 Dec; 48(50):11892-901. PubMed ID: 19894755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of drastic sequence alteration and D-amino acid incorporation on the membrane binding behavior of lytic peptides.
    Papo N; Shai Y
    Biochemistry; 2004 Jun; 43(21):6393-403. PubMed ID: 15157073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insertion and orientation of a synthetic peptide representing the C-terminus of the A1 domain of Shiga toxin into phospholipid membranes.
    Saleh MT; Ferguson J; Boggs JM; Gariépy J
    Biochemistry; 1996 Jul; 35(29):9325-34. PubMed ID: 8755710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformation and lipid binding properties of four peptides derived from the membrane-binding domain of CTP:phosphocholine cytidylyltransferase.
    Johnson JE; Rao NM; Hui SW; Cornell RB
    Biochemistry; 1998 Jun; 37(26):9509-19. PubMed ID: 9649334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of synergism between antimicrobial peptides magainin 2 and PGLa.
    Matsuzaki K; Mitani Y; Akada KY; Murase O; Yoneyama S; Zasloff M; Miyajima K
    Biochemistry; 1998 Oct; 37(43):15144-53. PubMed ID: 9790678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.